Relmada Therapeutics, Inc.
RLMD
Revenue
682.00
▼-1.17k▼-63.14%
3 Months ChangeAssets
14.88M
▼-6.24M▼-29.55%
3 Months ChangeLiabilities
5.41M
▲244.04k▲4.72%
3 Months ChangeFree Cash Flow
-981.64k
▲1.19M▲54.75%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-09
Form 8-K
ID: 0001213900-26-024918
2025-12-15
Form 8-K
ID: 0001213900-25-121461
2025-11-13
Form 8-K
ID: 0001213900-25-110088
2025-11-13
Form 10-Q
ID: 0001213900-25-109983
2025-11-05
Form 8-K
ID: 0001213900-25-106398
2025-11-04
Form 8-K
ID: 0001213900-25-105593
2025-09-17
Form 8-K
ID: 0001213900-25-088360
2025-09-16
Form 8-K
ID: 0001213900-25-087926
2025-09-10
Form 8-K
ID: 0001213900-25-086389
2025-09-02
Form 8-K
ID: 0001213900-25-082910